Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Heartseed, Inc. ( (JP:219A) ) just unveiled an update.
Heartseed Inc. reported its financial results for the three months ended January 31, 2025, showing a net loss of 478 million yen. Despite the negative financial performance, the company’s equity ratio remains strong at 93.7%, indicating a stable financial position. The forecast for the fiscal year ending December 31, 2025, anticipates significant growth in net sales, reflecting a 174% increase year-on-year, although the company expects to continue operating at a loss.
More about Heartseed, Inc.
Heartseed Inc. operates in the biotechnology industry and is listed on the Tokyo Stock Exchange. The company focuses on developing innovative treatments and therapies, leveraging its expertise in regenerative medicine to address unmet medical needs.
YTD Price Performance: -38.28%
Average Trading Volume: 1,265,762
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: Yen39.11B
For an in-depth examination of 219A stock, go to TipRanks’ Stock Analysis page.